Search Result

Results for "

Calmodulin

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Calmodulin (44) CaMK (46) 5-HT Receptor (2) Adenylate Cyclase (1) Adrenergic Receptor (5) AMPK (3) Amyloid-β (1) Antibiotic (1) Apoptosis (13) Autophagy (22) Bacterial (2) Calcineurin (2) Calcium Channel (9) Casein Kinase (1) Caspase (1) Checkpoint Kinase (Chk) (3) Cholinesterase (ChE) (2) DNA/RNA Synthesis (2) Dopamine Receptor (7) Drug Intermediate (1) EGFR (1) Endogenous Metabolite (2) Estrogen Receptor/ERR (1) Ferroptosis (1) Fungal (1) Histamine Receptor (2) Influenza Virus (5) Isotope-Labeled Compounds (1) MAP3K (2) MAPKAPK2 (MK2) (3) MEK (1) mGluR (2) Microtubule/Tubulin (1) Mitochondrial Metabolism (1) Mixed Lineage Kinase (1) Molecular Glues (1) Myosin (4) Na+/Ca2+ Exchanger (1) Na+/K+ ATPase (1) nAChR (2) NF-κB (1) NO Synthase (5) Nucleoside Antimetabolite/Analog (2) P-glycoprotein (5) P2X Receptor (1) Parasite (1) Phosphatase (4) Phosphodiesterase (PDE) (12) PKA (4) PKC (10) Potassium Channel (5) PROTACs (1) Proteasome (1) Reference Standards (8) RIP kinase (1) Ser/Thr Kinase (2) Src (1) Taste Receptor (1) Tau Protein (1) Trk Receptor (1)
By Research Areas:	Cancer (38) Cardiovascular Disease (11) Infection (10) Inflammation/Immunology (16) Metabolic Disease (17) Neurological Disease (62)

By Targets:

Calmodulin (44)

CaMK (46)

5-HT Receptor (2)

Adenylate Cyclase (1)

Adrenergic Receptor (5)

AMPK (3)

Amyloid-β (1)

Antibiotic (1)

Apoptosis (13)

Autophagy (22)

Bacterial (2)

Calcineurin (2)

Calcium Channel (9)

Casein Kinase (1)

Caspase (1)

Checkpoint Kinase (Chk) (3)

Cholinesterase (ChE) (2)

DNA/RNA Synthesis (2)

Dopamine Receptor (7)

Drug Intermediate (1)

EGFR (1)

Endogenous Metabolite (2)

Estrogen Receptor/ERR (1)

Ferroptosis (1)

Fungal (1)

Histamine Receptor (2)

Influenza Virus (5)

Isotope-Labeled Compounds (1)

MAP3K (2)

MAPKAPK2 (MK2) (3)

MEK (1)

mGluR (2)

Microtubule/Tubulin (1)

Mitochondrial Metabolism (1)

Mixed Lineage Kinase (1)

Molecular Glues (1)

Myosin (4)

Na+/Ca2+ Exchanger (1)

Na+/K+ ATPase (1)

nAChR (2)

NF-κB (1)

NO Synthase (5)

Nucleoside Antimetabolite/Analog (2)

P-glycoprotein (5)

P2X Receptor (1)

Parasite (1)

Phosphatase (4)

Phosphodiesterase (PDE) (12)

PKA (4)

PKC (10)

Potassium Channel (5)

PROTACs (1)

Proteasome (1)

Reference Standards (8)

RIP kinase (1)

Ser/Thr Kinase (2)

Src (1)

Taste Receptor (1)

Tau Protein (1)

Trk Receptor (1)

By Research Areas:

Cancer (38)

Cardiovascular Disease (11)

Infection (10)

Inflammation/Immunology (16)

Metabolic Disease (17)

Neurological Disease (62)

126

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Targets Recommended: Calmodulin CaMK

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-15465

KN-93 Maximum Cited Publications 95 Publications Verification	CaMK Autophagy	Cancer
KN-93 is a cell-permeable, reversible and competitive inhibitor calmodulin-dependent kinase type II (CaMKII) with a K_i of 370 nM.

HY-19805

STO-609 30+ Cited Publications	CaMK AMPK Autophagy	Metabolic Disease
STO-609 is a selective and cell-permeable inhibitor of the Ca ²⁺/calmodulin-dependent protein kinase kinase (CaM-KK), with K_i values of 80 and 15 ng/mL for recombinant CaM-KKα and CaM-KKβ, respectively. STO-609 inhibits AMP-activated protein kinase kinase (AMPKK) activity in HeLa cell lysates with an IC₅₀ ~0.02 g/ml.

HY-N6732

K-252a 25+ Cited Publications SF2370; Antibiotic K 252a; Antibiotic SF 2370	Autophagy PKA PKC Trk Receptor CaMK	Infection Inflammation/Immunology
K-252a, a staurosporine analog, inhibits protein kinase, with IC₅₀ values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca ²⁺/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively . K-252a is a potent inhibitor (IC₅₀ of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene .

HY-B1077

Penfluridol 5+ Cited Publications R-16341	Calcium Channel Dopamine Receptor Autophagy Apoptosis	Neurological Disease Inflammation/Immunology Cancer
Penfluridol (R-16341) is a potent, long-acting, first-generation, oral diphenylbutylpiperidine antipsychotic agent by targeting D2-like dopamine receptor. Penfluridol effectively inhibits TNFα-induced NF-κB activation and alleviates the severity of arthritis and colitis in vivo. Penfluridol is a Ca2+-calmodulin inhibitor. Penfluridol induces apoptosis and autophagy. Penfluridol is used for chronic schizophrenia, acute psychosis, Tourette syndrome and autoimmune diseases. Penfluridol inhibites the growth of E. faecalis planktonic cells with the MIC of 7.81 μg/ml .

HY-100912

W-7 hydrochloride 5+ Cited Publications	Phosphodiesterase (PDE) Myosin Apoptosis Calmodulin Potassium Channel	Cancer
W-7 hydrochloride is a selective *calmodulin* antagonist. W-7 hydrochloride inhibits the Ca ²⁺-calmodulin-dependent phosphodiesterase and myosin light chain kinase with IC₅₀ values of 28 μM and 51 μM, respectively. W-7 hydrochloride induces apoptosis and has antitumor and vascular relaxing activity. W-7 hydrochloride is a blocker of Kv4.3 and can be used for research of arrhythmias .

HY-103319

Calmidazolium chloride 4 Publications Verification R 24571	Autophagy Calmodulin	Neurological Disease Cancer
Calmidazolium chloride (R 24571) is a *calmodulin* antagonist, antagonizing CaM-dependent phosphodiesterase and calmodulin-induced activation of erythrocyte Ca2+-transporting ATPase with IC₅₀s of 0.15 and 0.35 μM, respectively . Also in anti-cancer research . Calmidazolium binds to calmodulin with a K_d of 3 nM.

HY-13290

KN-62 10+ Cited Publications	CaMK P2X Receptor	Metabolic Disease Cancer
KN-62 is a selective and reversible inhibitor of calmodulin-dependent protein kinase II (CaMK-II) with a K_i of 0.9 μM for rat brain CaMK-II. KN-62 directly binds to the calmodulin binding site of CaMK-II. KN-62 displays noncompetitive antagonism at P2X₇ receptors in HEK293 cells, with an IC₅₀ value of approximately 15 nM.

HY-D0987

Stains-All	Calmodulin	Others
Stains-All, a cationic carbocyanine dye, is a convenient probe to study the structural features of the individual calcium-binding sites of calmodulin (CaM) and related calcium-binding proteins (CaBP) .

HY-B0532

Trifluoperazine 5+ Cited Publications	Dopamine Receptor Adrenergic Receptor P-glycoprotein CaMK Influenza Virus Autophagy	Neurological Disease
Trifluoperazine, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine is a potent α1-adrenergic receptor antagonist. Trifluoperazine is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine is a *calmodulin* inhibitor, and also inhibits P-glycoprotein. Trifluoperazine can be used for the research of schizophrenia. Trifluoperazine acts as a reversible inhibitor of influenza virus morphogenesis .

HY-15465B

KN-93 phosphate Maximum Cited Publications 95 Publications Verification	CaMK Autophagy	Cancer
KN-93 phosphate is a cell-permeable, reversible and competitive inhibitor calmodulin-dependent kinase type II (CaMKII) with a Ki of 370 nM .

HY-B0532A

Trifluoperazine dihydrochloride 5+ Cited Publications	Dopamine Receptor Adrenergic Receptor CaMK P-glycoprotein Influenza Virus Autophagy	Neurological Disease Cancer
Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a *calmodulin* inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis .

HY-15465A

KN-93 hydrochloride Maximum Cited Publications 95 Publications Verification	CaMK Autophagy	Cancer
KN-93 hydrochloride is a cell-permeable, reversible and competitive inhibitor calmodulin-dependent kinase type II (CaMKII) with a K_i of 370 nM.

HY-N6781

Ophiobolin A	Phosphodiesterase (PDE)	Infection Cancer
Ophiobolin A, a fungal metabolite and a phytotoxin, is a potent and irreversibly inhibitor of calmodulin-activated cyclic nucleotide phosphodiesterase, with an IC₅₀ value of 9 μM. Ophiobolin A antimicrobial and anticancer activity .

HY-115719

NR162	Ser/Thr Kinase	Neurological Disease
NR162 is a selective CASK (Ca ²⁺/calmodulin-dependent Ser/Thr kinase) inhibitor with an IC₅₀ of 80 nM and a Kd of 22 nM. NR162 shows about 50-fold selectivity for CASK than TYRO3. NR162 targets the unique GFG motif of CASK and has excellent shape complementarity to the CASK ATP binding pocket. NR162 can be used for the research of neurological diseases .

HY-P1077

CALP1 3 Publications Verification	mGluR Phosphodiesterase (PDE) Apoptosis Calmodulin	Inflammation/Immunology
CALP1 is a calmodulin (CaM) agonist (K_d of 88 µM) with binding to the CaM EF-hand/Ca ²⁺-binding site. CALP1 blocks calcium influx and apoptosis (IC₅₀ of 44.78 µM) through inhibition of calcium channel opening. CALP1 blocks glutamate receptor channels and blocks a store-operated nonselective cation channel. CALP1 activates CaM-dependent phosphodiesterase activity .

HY-105118A

Zaldaride maleate CGS-9343B; KW 5617	Calmodulin	Neurological Disease Metabolic Disease Inflammation/Immunology
Zaldaride maleate (CGS-9343B) is a potent, orally active and selective inhibitor of *calmodulin. Zaldaride maleate inhibits CaM (calmodulin)-stimulated cAMP phosphodiesterase activity, with an IC₅₀* of 3.3 nM . Zaldaride maleate prevents estrogen-induced transcription activation by ER, reversibly blocks voltage-activated Na ⁺, Ca ²⁺ and K ⁺ currents in PC12 cells and inhibits nAChR .

HY-110140

(E)-KN-93 phosphate	CaMK	Cardiovascular Disease Neurological Disease
(E)-KN-93 phosphate is a *Ca ²⁺/calmodulin-dependent* protein kinase II (CaMKII) inhibitor with IC₅₀ values of 9 μM and 3 μM against CaMKIIδ_Monomer and CaMKIIδ_Dodecamer**, respectively. (E)-KN-93 phosphate can be used in research on epilepsy, depression, and arrhythmias. .

HY-P1805

Calmodulin Binding Peptide 1	Calmodulin	Neurological Disease
Calmodulin Binding Peptide 1 is a high-affinity (pM) CaM-binding peptide derived from smooth muscle myosin light chain kinase (MLCK peptide). The interface of the complex formed by Calmodulin Binding Peptide 1 and Ca ²⁺-CaM can be specifically bound by small-molecule inhibitors, serving as a key target for selective regulation of smooth muscle contraction and development of anti-CaM drugs .

HY-P1077A

CALP1 TFA 3 Publications Verification	mGluR Phosphodiesterase (PDE) Apoptosis Calmodulin	Inflammation/Immunology
CALP1 TFA is a calmodulin (CaM) agonist (K_d of 88 µM) with binding to the CaM EF-hand/Ca ²⁺-binding site. CALP1 TFA blocks calcium influx and apoptosis (IC₅₀ of 44.78 µM) through inhibition of calcium channel opening. CALP1 TFA blocks glutamate receptor channels and blocks a store-operated nonselective cation channel. CALP1 TFA activates CaM-dependent phosphodiesterase activity .

HY-P1075

CALP3 2 Publications Verification	Calcium Channel	Neurological Disease Cancer
CALP3, a Ca ²⁺-like peptide, is a potent Ca ²⁺ channel blocker that activates EF hand motifs of Ca ²⁺-binding proteins. CALP3 can functionally mimic increased [Ca ²⁺]_i by modulating the activity of Calmodulin (CaM), Ca ²⁺ channels and pumps. CALP3 has the potential in controlling apoptosis in diseases such as AIDS or neuronal loss due to ischemia .

HY-P0225

Autocamtide 2 Autocamtide II	CaMK Autophagy	Neurological Disease
Autocamtide 2 is a highly selective peptide substrate of calcium/calmodulin-dependent protein kinase II (CaMKII). It can be used in the CaMKII activity assay.

HY-100910

W-13 hydrochloride	CaMK	Cancer
W-13 hydrochloride is a *calmodulin* antagonist. W-13 hydrochloride can inhibit Tamoxifen (HY-13757A)-resistant human breast cancer cell growth .

HY-100779

Rimacalib SMP 114	CaMK Autophagy	Metabolic Disease
Rimacalib (SMP 114) is a *Ca ²⁺/calmodulin-dependent* protein kinase II (CaMKII) inhibitor, with IC₅₀s of ~1 μM for CaMKIIα to ~30 μM for CaMKIIγ** .

HY-W039943

Acetyl-cyclosporin A aldehyde	Molecular Glues	Cancer
Acetyl-cyclosporin A aldehyde is an acetylated Cyclosporin A (HY-B0579) derivative with a reducing aldehyde group. Cyclosporin A is a potent calmodulin inhibitor and cyclophilin binder that can target the nuclear translocation of NF-AT and cause mitochondrial damage.

HY-P1247

Calcineurin autoinhibitory peptide	Phosphatase	Neurological Disease
Calcineurin autoinhibitory peptide is a selective inhibitor of *Ca ²⁺/calmodulin-dependent* protein phosphatase (calcineurin), with an IC₅₀** of ~10 μM. Calcineurin autoinhibitory peptide could protect neurons from excitatory neuronal death .

HY-100913

W-7 isomer hydrochloride	Calmodulin	Cancer
W-7 isomer hydrochloride is an isomer of W-7 hydrochloride (HY-100912). W-7 hydrochloride is a selective *calmodulin* antagonist .

HY-B1726

Phenacaine Holocaine	Phosphodiesterase (PDE)	Metabolic Disease
Phenacaine (Holocaine) is a local agent that can suppress or relieve pain. Phenacaine inhibits the specific calmodulin-dependent stimulation of erythrocyte Ca ²⁺-ATPase and cyclic nucleotide phosphodiesterases from brain and heart .

HY-100911

W-5 hydrochloride	Calmodulin	Neurological Disease
W-5 hydrochloride is a *calmodulin* antagonist. W-5 hydrochloride inhibits phosphodiesterase activation with an IC₅₀ value of 240 µM. W-5 hydrochloride can be used as a negative control for W-7 (HY-100912) .

HY-168905

SGC-CAMKK2-1	Calmodulin	Cancer
SGC-CAMKK2-1, a chemical probe, is the selective, inhibitor for calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) with an IC₅₀ of 30 nM. SGC-CAMKK2-1 inhibits AMPK phosphorylation in cell C4-2 with an IC₅₀ of 1.6 μM .

HY-N10772

Albanin A	Calcium Channel Calmodulin Adenylate Cyclase	Neurological Disease Inflammation/Immunology
Albanin A, a flavonoid, suppresses glutamate release by decreasing *Ca ²⁺/calmodulin/adenylate* Cyclase 1 (AC1)** activation in synaptosomes and exerts neuroprotective effect in vivo. Albanin A has anti-inflflammatory activity .

HY-120997

E6 Berbamine Berbamine p-nitrobenzoate	Calmodulin Myosin Phosphodiesterase (PDE)	Cardiovascular Disease Cancer
E6 Berbamine (Berbamine p-nitrobenzoate) is a potent calmodulin (CaM) antagonist. E6 Berbamine inhibits the activities of calmodulin-dependent myosin light chain kinase (MLCK) and phosphodiesterase (PDE). E6 Berbamine exhibits anti-leukemic activity. E6 Berbamine can be used in research related to cardiovascular abnormalities and chronic myeloid leukemia .

HY-P1076A

CALP2 TFA	Calmodulin	Inflammation/Immunology
CALP2 TFA is a calmodulin (CaM) antagonist (K_d of 7.9 µM) with high affinity for binding to the CaM EF-hand/Ca ²⁺-binding site. CALP2 TFA inhibits CaM-dependent phosphodiesterase activity and increases intracellular Ca ²⁺ concentrations. CALP2 TFA potently inhibits of adhesion and degranulation. CALP2 TFA is also a strong activator of alveolar macrophages .

HY-N7503

Psoralenoside	Histamine Receptor Calcium Channel Calmodulin	Infection Metabolic Disease Cancer
Psoralenoside is a benzofuran glycoside from Psoralea corylifolia . Psoralenoside exhibits high binding affinities against histaminergic H₁, *calmodulin, and voltage-gated L-type calcium channels* (E-value≥-6.5 Kcal/mol) . Psoralenoside shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity .

HY-130368

W-7 5+ Cited Publications	Calmodulin Potassium Channel Phosphodiesterase (PDE) Myosin Apoptosis	Cardiovascular Disease
W-7 is a selective *calmodulin* antagonist. W-7 inhibits the Ca ²⁺-calmodulin-dependent phosphodiesterase and myosin light chain kinase with IC₅₀ values of 28 μM and 51 μM, respectively. W-7 induces apoptosis and has antitumor and vascular relaxing activity. W-7 is a blocker of Kv4.3 and can be used for research of arrhythmias .

HY-P3811A

Autocamtide-3 acetate	CaMK	Neurological Disease
Autocamtide-3 acetate, a 13-amino-acid peptide containing Thr287, is a selective *CaMKII (Ca ²⁺/calmodulin-dependent* kinase II)** (CaMK) substrate .

HY-P0271A

Syntide 2 TFA 2 Publications Verification	CaMK	Neurological Disease
Syntide 2 (TFA), a Ca ²⁺- and calmodulin (CaM)-dependent protein kinase II (CaMKII) substrate peptide, selectively inhibits the gibberellin (GA) response, leaving constitutive and abscisic acid-regulated events unaffected .

HY-146268

CaMKIIα-IN-1	CaMK	Neurological Disease
CaMKIIα-IN-1 (Compound 4d) is an orally active *Ca ²⁺/calmodulin-dependent* protein kinase II α (CaMKIIα) inhibitor with a K_D** of 219 nM for CaMKIIα WT hub. CaMKIIα-IN-1 has good metabolic stability .

HY-W013857

Lavendustin C	CaMK EGFR Src	Cancer
Lavendustin C is a potent *Ca ²⁺ calmodulin-dependent kinase II (CaMK II)* inhibitor with an IC₅₀ of 0.2 µM. Lavendustin C inhibits EGFR-associated tyrosine kinase (IC₅₀=0.012 µM) and pp60 ^c-src(+) kinase (IC₅₀=0.5 µM) .

HY-19230

DY-9760e	Calmodulin NO Synthase CaMK Calcineurin Proteasome Caspase	Cardiovascular Disease
DY-9760e is a calmodulin (CaM) inhibitor. DY-9760e selectively inhibits the activity of various calmodulin-dependent enzymes by antagonizing the Ca²⁺/CaM complex, exhibiting the strongest inhibitory activity against nNOS, CaM kinase II, and calcineurin (K_i: 0.9, 1.4, and 2.0 μM, respectively). DY-9760e inhibits excessive nitric oxide production and protein tyrosine nitration, as well as the activation of calpain and caspase-3. DY-9760e reduces infarct size, improves cardiac function, and inhibits oxidative stress and cell death. DY-9760e can be used in research on the treatment of myocardial infarction, cerebral ischemia, and other diseases .

HY-100263

Metofenazate Methophenazine	Autophagy Calmodulin	Neurological Disease
Metofenazate is a selective *calmodulin* inhibitor.

HY-115745

Calmodulin antagonist-1	Calmodulin	Cardiovascular Disease
Calmodulin antagonist-1 (A-5) is a calmodulin (CaM) antagonist. Calmodulin antagonist-1 inhibits calmodulin-activated Ca ²⁺-phosphodiesterase (PDE) (IC₅₀=66 μM). Calmodulin antagonist-1 also inhibits trypsin-treated Ca ²⁺-PDE (IC₅₀=560 μM) in a competitive fashion with respect to cyclic GMP .

HY-114928

Deiodoamiodarone L 3937; Dideiodo Amiodarone	Drug Intermediate	Others
Deiodoamiodarone (L 3937; Dideiodo Amiodarone) is an intermediate of amiodarone. Amiodarone is a potent calmodulin antagonist .

HY-133782

Fluphenazine-N-2-chloroethane hydrochloride SKF-7171A hydrochloride	Calmodulin	Neurological Disease
Fluphenazine-N-2-chloroethane (SKF-7171A) hydrochloride is a potent irreversible *calmodulin* antagonist .

HY-W170020

PTCA	CaMK	Metabolic Disease
PTCA is a potent *Ca2+/calmodulin-dependent protein kinase II α (CaMKIIα)* ligand with a pK_i value of 7.2 .

HY-125957

A-3 hydrochloride	PKA Casein Kinase CaMK PKC	Others
A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases. It against PKA (K_i=4.3 µM), casein kinase II (K_i=5.1 µM) and myosin light chain kinase (MLCK) (K_i=7.4 µM). A-3 hydrochloride also inhibits PKC and casein kinase I with K_i values of 47 µM and 80 µM, respectively .

HY-19805A

STO-609 acetate	CaMK AMPK Autophagy	Metabolic Disease
STO-609 acetate is a selective and cell-permeable inhibitor of the Ca ²⁺/calmodulin-dependent protein kinase kinase (CaM-KK), with K_i values of 80 and 15 ng/mL for recombinant CaM-KKα and CaM-KKβ, respectively. STO-609 acetate inhibits AMP-activated protein kinase kinase (AMPKK) activity in HeLa cell lysates with an IC₅₀ ~0.02 g/ml.

HY-P1479

Calmodulin-Dependent Protein Kinase II (290-309)	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) is a potent CaMK antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II .

HY-P10316

CaMKI(299-320) Calmodulin-Dependent Protein Kinase I (299-320) Binding Domain	CaMK	Others
CaMKI (299-320) refers to a peptide consisting of residues 299-320 of Calcium/calmodulin-dependent protein kinase I (CaMKI). CaMKI (299-320), as a protein kinase, has a high affinity interaction with Ca ²⁺-CAM (K_d≤1 nM≤1 nM), which can phosphorylate specific substrate proteins, thereby regulating their activity. CaMKI (299-320) contains the CAM-binding domain and the self-inhibition domain, and CaMKI (299-320) can be used to study cell physiological processes, including cell proliferation, differentiation, and apoptosis .

HY-100914

A-7 hydrochloride Ophobolin A	Calmodulin	Cancer
A-7 hydrochloride (Ophobolin A) is a *calmodulin* antagonist and can be used for the research of cancer .

HY-19025

CV-159	Calmodulin	Inflammation/Immunology
CV-159 is a unique dihydropyridine Ca ²⁺ antagonist with an anti-calmodulin (CaM) action, and has antiinflammatory activities.

Cat. No.	Product Name	Target	Research Area

HY-P1821

Myelin Basic Protein 2 Publications Verification MHP4-14	PKC	Neurological Disease
Myelin Basic Protein (MHP4-14), a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (K_m=7 μM). Myelin Basic Protein is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca ²⁺/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts .

HY-P10638

TAT-CN21	CaMK	Cardiovascular Disease Neurological Disease
TAT-CN21 is a potent CaMKII inhibitor with an IC₅₀ of 77.2 nM. TAT-CN21 inhibits both calcium/calmodulin-dependent and autonomously activated CaMKII, blocks glutamate-induced translocation of CaMK IIα, and reverses the enhanced phosphorylation of CaMKII at Thr286 following excitotoxic injury. TAT-CN21 shows application potential in studies related to ischemic stroke by reducing neuronal excitotoxicity and exacerbating pre-existing long-term neuronal death prior to injury. TAT-CN21 improves definitive behaviors in rats with residual nerve injury without altering indicators such as mechanical/thermal hyperalgesia or spatial memory. TAT-CN21 can also be used in studies related to neuropathic pain .

HY-P1077

CALP1 3 Publications Verification	mGluR Phosphodiesterase (PDE) Apoptosis Calmodulin	Inflammation/Immunology
CALP1 is a calmodulin (CaM) agonist (K_d of 88 µM) with binding to the CaM EF-hand/Ca ²⁺-binding site. CALP1 blocks calcium influx and apoptosis (IC₅₀ of 44.78 µM) through inhibition of calcium channel opening. CALP1 blocks glutamate receptor channels and blocks a store-operated nonselective cation channel. CALP1 activates CaM-dependent phosphodiesterase activity .

HY-P1805

Calmodulin Binding Peptide 1	Calmodulin	Neurological Disease
Calmodulin Binding Peptide 1 is a high-affinity (pM) CaM-binding peptide derived from smooth muscle myosin light chain kinase (MLCK peptide). The interface of the complex formed by Calmodulin Binding Peptide 1 and Ca ²⁺-CaM can be specifically bound by small-molecule inhibitors, serving as a key target for selective regulation of smooth muscle contraction and development of anti-CaM drugs .

HY-P1077A

CALP1 TFA 3 Publications Verification	mGluR Phosphodiesterase (PDE) Apoptosis Calmodulin	Inflammation/Immunology
CALP1 TFA is a calmodulin (CaM) agonist (K_d of 88 µM) with binding to the CaM EF-hand/Ca ²⁺-binding site. CALP1 TFA blocks calcium influx and apoptosis (IC₅₀ of 44.78 µM) through inhibition of calcium channel opening. CALP1 TFA blocks glutamate receptor channels and blocks a store-operated nonselective cation channel. CALP1 TFA activates CaM-dependent phosphodiesterase activity .

HY-P1075

CALP3 2 Publications Verification	Calcium Channel	Neurological Disease Cancer
CALP3, a Ca ²⁺-like peptide, is a potent Ca ²⁺ channel blocker that activates EF hand motifs of Ca ²⁺-binding proteins. CALP3 can functionally mimic increased [Ca ²⁺]_i by modulating the activity of Calmodulin (CaM), Ca ²⁺ channels and pumps. CALP3 has the potential in controlling apoptosis in diseases such as AIDS or neuronal loss due to ischemia .

HY-P0225

Autocamtide 2 Autocamtide II	CaMK Autophagy	Neurological Disease
Autocamtide 2 is a highly selective peptide substrate of calcium/calmodulin-dependent protein kinase II (CaMKII). It can be used in the CaMKII activity assay.

HY-P1247

Calcineurin autoinhibitory peptide	Phosphatase	Neurological Disease
Calcineurin autoinhibitory peptide is a selective inhibitor of *Ca ²⁺/calmodulin-dependent* protein phosphatase (calcineurin), with an IC₅₀** of ~10 μM. Calcineurin autoinhibitory peptide could protect neurons from excitatory neuronal death .

HY-16129

CBP-501	Calmodulin Checkpoint Kinase (Chk) MAPKAPK2 (MK2) MAP3K	Cancer
CBP-501, a cell-permeable *calmodulin*-binding peptide and a G2-abrogating drug candidate, inhibits the activity of multiple Ser ²¹⁶-specific kinases, such as MAPKAP-K2, C-Tak1, CHK1 and CHK2, with IC₅₀ values of 0.9 μM, 1.4 μM 3.4 μM and 6.5 μM, respectively. CBP-501 is used for various types of cancer .

HY-P1076A

CALP2 TFA	Calmodulin	Inflammation/Immunology
CALP2 TFA is a calmodulin (CaM) antagonist (K_d of 7.9 µM) with high affinity for binding to the CaM EF-hand/Ca ²⁺-binding site. CALP2 TFA inhibits CaM-dependent phosphodiesterase activity and increases intracellular Ca ²⁺ concentrations. CALP2 TFA potently inhibits of adhesion and degranulation. CALP2 TFA is also a strong activator of alveolar macrophages .

HY-P3811A

Autocamtide-3 acetate	CaMK	Neurological Disease
Autocamtide-3 acetate, a 13-amino-acid peptide containing Thr287, is a selective *CaMKII (Ca ²⁺/calmodulin-dependent* kinase II)** (CaMK) substrate .

HY-P0271A

Syntide 2 TFA 2 Publications Verification	CaMK	Neurological Disease
Syntide 2 (TFA), a Ca ²⁺- and calmodulin (CaM)-dependent protein kinase II (CaMKII) substrate peptide, selectively inhibits the gibberellin (GA) response, leaving constitutive and abscisic acid-regulated events unaffected .

HY-P1821A

Myelin basic protein (4-14) TFA 2 Publications Verification MHP4-14 TFA	PKC	Neurological Disease
Myelin Basic Protein (MHP4-14) TFA, a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (K_m=7 μM). Myelin Basic Protein TFA is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca ²⁺/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts .

HY-P1479

Calmodulin-Dependent Protein Kinase II (290-309)	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) is a potent CaMK antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II .

HY-P10316

CaMKI(299-320) Calmodulin-Dependent Protein Kinase I (299-320) Binding Domain	CaMK	Others
CaMKI (299-320) refers to a peptide consisting of residues 299-320 of Calcium/calmodulin-dependent protein kinase I (CaMKI). CaMKI (299-320), as a protein kinase, has a high affinity interaction with Ca ²⁺-CAM (K_d≤1 nM≤1 nM), which can phosphorylate specific substrate proteins, thereby regulating their activity. CaMKI (299-320) contains the CAM-binding domain and the self-inhibition domain, and CaMKI (299-320) can be used to study cell physiological processes, including cell proliferation, differentiation, and apoptosis .

HY-P10071

CaMKII inhibitory peptide KIIN Calmodulin Kinase IINtide; CaM-KIIN; CaM-KIINβ	CaMK	Others
CaMKII inhibitory peptide KIIN is a potent inhibitor of CaMKII .

HY-P0271

Syntide 2	CaMK Autophagy	Neurological Disease
Syntide 2, a Ca ²⁺- and calmodulin (CaM)-dependent protein kinase II (CaMKII) substrate peptide, selectively inhibits the gibberellin (GA) response, leaving constitutive and abscisic acid-regulated events unaffected .

HY-P5525

AC3-I, myristoylated Autocamtide-3 Derived Inhibitory Peptide	CaMK	Others
AC3-I, myristoylated is a biological active peptide. (This is a myristoylated form of Autocamtide-3-Derived Inhibitory Peptide (AC3-I), a highly specific inhibitor of Calmodulin-Dependent Protein Kinase ll (CaMKII) that is resistant to proteolysis. AC3-I is derived from Autocamtide-3, a substrate for CaMKII, with the Thr-9 phosphorylation site substituted with Ala.)

HY-16129A

CBP-501 acetate	Calmodulin MAP3K MAPKAPK2 (MK2) Checkpoint Kinase (Chk)	Cancer
CBP-501 acetate, a cell-permeable *calmodulin*-binding peptide and a G2-abrogating drug candidate, inhibits the activity of multiple Ser ²¹⁶-specific kinases, such as MAPKAP-K2, C-Tak1, CHK1 and CHK2, with IC₅₀ values of 0.9 μM, 1.4 μM 3.4 μM and 6.5 μM, respectively. CBP-501 acetate is used for various types of cancer .

HY-P3944

Calmodulin Dependent Protein Kinase Substrate	CaMK	Neurological Disease
Calmodulin Dependent Protein Kinase Substrate is a Ca ²⁺- and calmodulin (CaM)-dependent protein kinase (CaMK) substrate peptide. Calmodulin Dependent Protein Kinase Substrate is a synthetic peptide substrate for protein kinases .

HY-P3943

Calmodulin Dependent Protein Kinase Substrate Analog	CaMK	Neurological Disease
Calmodulin Dependent Protein Kinase Substrate Analog is a Ca ²⁺- and calmodulin (CaM)-dependent protein kinase (CaMK) substrate peptide. Calmodulin Dependent Protein Kinase Substrate Analog is a synthetic peptide substrate for protein kinases .

HY-P1874

Calmodulin-Dependent Protein Kinase II (281-309)	Calmodulin	Neurological Disease
Calmodulin-Dependent Protein Kinase II (281-309) is a peptide of calcium/calmodulin-dependent protein kinase II (CaM-kinase II) .

HY-P1479A

Calmodulin-Dependent Protein Kinase II(290-309) acetate	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) acetate is a potent CaMK antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II .

HY-P5987

Calmodulin Kinase IINtide, Myristoylated Myr-CaMKIINtide	CaMK	Neurological Disease
Calmodulin Kinase IINtide, Myristoylated (Myr-CaMKIINtide) is a selective and noncompetitive inhibitor of CaMKII .

HY-P10499

*[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302)*	CaMK	Others
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors .

HY-P1076

CALP2	Calmodulin	Inflammation/Immunology
CALP2 is a calmodulin (CaM) antagonist ( (K_d of 7.9 µM)) with high affinity for binding to the CaM EF-hand/Ca ²⁺-binding site. CALP2 inhibits CaM-dependent phosphodiesterase activity and increases intracellular Ca ²⁺ concentrations. CALP2 potently inhibits of adhesion and degranulation. CALP2 is also a strong activator of alveolar macrophages .

HY-P1075A

CALP3 TFA	Calcium Channel	Neurological Disease Cancer
CALP3 TFA, a Ca ²⁺-like peptide, is a potent Ca ²⁺ channel blocker that activates EF hand motifs of Ca ²⁺-binding proteins. CALP3 TFA can functionally mimic increased [Ca ²⁺]_i by modulating the activity of Calmodulin (CaM), Ca ²⁺ channels and pumps. CALP3 TFA has the potential in controlling apoptosis in diseases such as AIDS or neuronal loss due to ischemia .

HY-P2471

Neurogranin (48-76), mouse	Calmodulin	Neurological Disease
Neurogranin (48-76), mouse is a peptide corresponding to residues 48-76 of Neurogranin. Neurogranin, a calmodulin-binding protein, is exclusively expressed in the post-synapse, and mediates NMDAR driven synaptic plasticity by regulating the calcium-calmodulin (Ca ²⁺-CaM) pathway .

HY-P10811

Na+-Ca2+ Exchanger XIP	Na+/Ca2+ Exchanger	Neurological Disease
Na ⁺-Ca ²⁺ Exchanger inhibitory peptide (XIP) is a Na ⁺-Ca ²⁺ exchanger inhibitor with a K_i of 200 nM. Na ⁺-Ca ²⁺ Exchanger inhibitory peptide inhibits the Na ⁺-dependent Ca ²⁺ uptake and the Na ⁺-dependent Ca ²⁺ efflux of sarcolemmal vesicles in a noncompetitive manner .

HY-P0184

Camstatin	NO Synthase	Neurological Disease
Camstatin, a functionally active 25-residue fragment of PEP-19's IQ motif, binds calmodulin and inhibits neuronal nitric oxide (NO) synthase .

HY-P3811

Autocamtide-3	CaMK	Neurological Disease
Autocamtide-3, a 13-amino-acid peptide containing Thr287, is a selective *CaMKII (Ca ²⁺/calmodulin-dependent* kinase II)** (CaMK) substrate .

HY-P0184A

Camstatin TFA	NO Synthase	Neurological Disease
Camstatin TFA, a functionally active 25-residue fragment of PEP-19's IQ motif, binds calmodulin and inhibits neuronal nitric oxide (NO) synthase .

HY-P5436

SK-MLCK M13	Peptides	Others
SK-MLCK M13 is a biological active peptide. (M-13 is a peptide that represents CAM-binding domain of Calmodulin (CaM) target proteins. CaM is an ubiquitous Ca2+ binding protein.)

HY-P1716

Neuropeptide DF2	PKC	Neurological Disease
Neuropeptide DF2 is a DRNFLRFamide neuropeptide orignally isolated from crayfish. which enhances transmitter release and stimulates the amplitude of excitatory post-synaptic potentials (EPSP) through the calcium/calmodulin-dependent protein kinase .

HY-P1247A

Calcineurin autoinhibitory peptide TFA	Phosphatase	Neurological Disease
Calcineurin autoinhibitory peptide TFA is a selective inhibitor of *Ca ²⁺/calmodulin-dependent* protein phosphatase (calcineurin), with an IC₅₀** of ~10 μM. Calcineurin autoinhibitory peptide TFA could protect neurons from excitatory neuronal death .

HY-P10367

Ziptide	MAPKAPK2 (MK2) Checkpoint Kinase (Chk) AMPK	Others
Ziptide is a substrate for MAPK activated protein kinase 2 (MAPKAPK2, K_m = 5 μM), MAPKAPK3 (K_m = 30 μM), PARK (K_m = 40 μM), checkpoint kinase 1 (Chk1, K_m = 5 μM), AMP-activated protein kinase (AMPK, K_m = 75 μM), and calcium/calmodulin-dependent protein kinase II (CamKII, K_m = 300 μM) .

HY-P10393

ERα17p ERα (295-311)	Apoptosis	Cancer
ERα17p (ERα 295-311) is the epitope of the CaM binding site on the estrogen receptor α (ER), which interacts with calmodulin (CaM) in a calcium-dependent manner. ERα17p regulates the migration of cancer cells MCF-7, SK-BR-3, T47D, and MDA-MB-231 through Rho/ROCK and PI3K/Akt signaling pathways. ERα17p inhibits proliferations of breast cancer cells, induces apoptosis, and inhibits tumor growth in mouse models .

HY-P2209

Nummularine B Daechuine S27; N-Demethylamphibine H	Parasite Phosphodiesterase (PDE)	Infection
Nummularine B (Daechuine S27; N-Demethylamphibine H) is an anti-parasite agent. Nummularine B inhibits calmodulin-dependent phosphodiesterase activity with an IC₅₀ of 16.8 μM. Nummularine B inhibits the growth of Plasmodium and Leishmania donovani in vitro. Nummularine B inhibits the calmodulin-dependent activity of actomyosin Ca ²⁺-ATPase. Nummularine B is applicable to research related to malaria and visceral leishmaniasis .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N6732

K-252a 25+ Cited Publications SF2370; Antibiotic K 252a; Antibiotic SF 2370	Alkaloids Structural Classification Microorganisms Classification of Application Fields Inflammation/Immunology Disease Research Fields Indole Alkaloids Source Classification	Autophagy PKA PKC Trk Receptor CaMK
K-252a, a staurosporine analog, inhibits protein kinase, with IC₅₀ values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca ²⁺/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively . K-252a is a potent inhibitor (IC₅₀ of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene .

HY-Z0478

(-)-Limonene 1 Publications Verification (S)-(-)-Limonene	Cardiovascular Disease Other Monoterpenes Microorganisms Classification of Application Fields Terpenoids Rutaceae Plants Citrus Disease Research Fields Source Classification	Bacterial Antibiotic CaMK
(-)-Limonene ((S)-(-)-Limonene) is orally active and can cause mild bronchoconstriction. (-)-Limonene alleviates cytosolic and mitochondrial oxidative stress by inhibiting the increase of calcium ions (Ca ²⁺) and Ca ²⁺/calmodulin-dependent protein kinase II (CaMKII). It also exerts anti-stress effects by inhibiting the activity of the hypothalamic-pituitary-adrenal (HPA) axis. Additionally, (-)-Limonene can be used as an antibacterial agent in aquaculture .

HY-N6781

Ophiobolin A	Infection Microorganisms Classification of Application Fields Terpenoids Sesquiterpenes Disease Research Fields Source Classification	Phosphodiesterase (PDE)
Ophiobolin A, a fungal metabolite and a phytotoxin, is a potent and irreversibly inhibitor of calmodulin-activated cyclic nucleotide phosphodiesterase, with an IC₅₀ value of 9 μM. Ophiobolin A antimicrobial and anticancer activity .

HY-N1989

Bacoside A	Triterpenes Structural Classification Classification of Application Fields Terpenoids Scrophulariaceae Metabolic Disease Plants Disease Research Fields Bacopa monnieri (Linn.) Wettst. Source Classification	Na+/K+ ATPase CaMK Apoptosis Cholinesterase (ChE) NO Synthase NF-κB
Bacoside A is an orally active, blood-brain barrier-permeable triterpenoid saponin that modulates the activities of ATPases, AChE, CaMK2A and iNOS. Derived from Bacopa monniera. Bacoside A exerts significant antioxidant, anti-inflammatory and anti-apoptotic effects by maintaining ion balance, scavenging reactive oxygen species, stabilizing cell membranes, and regulating the expression of NF-κB and apoptosis-related proteins. Bacoside A counteracts morphine-induced reductions in Na ⁺/K ⁺-ATPase, Ca ²⁺-ATPase and Mg ²⁺-ATPase activities, increases mitochondrial membrane potential, and decreases intracellular reactive oxygen species levels. Bacoside A specifically binds to calcium/calmodulin-dependent protein kinase IIA to trigger endoplasmic reticulum calcium release. Bacoside A exhibits non-apoptotic cytotoxicity against glioblastoma cells while protecting normal nerve cells from stress-induced damage. Bacoside A is applicable to the research of Parkinson's disease and glioblastoma multiforme .

HY-N10772

Albanin A	Flavonoids Morus nigra Linn. Plants Moraceae Other Flavonoids Source Classification	Calcium Channel Calmodulin Adenylate Cyclase
Albanin A, a flavonoid, suppresses glutamate release by decreasing *Ca ²⁺/calmodulin/adenylate* Cyclase 1 (AC1)** activation in synaptosomes and exerts neuroprotective effect in vivo. Albanin A has anti-inflflammatory activity .

HY-N7503

Psoralenoside	Infection Classification of Application Fields Simple Phenylpropanols Leguminosae Metabolic Disease Phenylpropanoids Psoralea corylifolia L. Plants Disease Research Fields Source Classification	Histamine Receptor Calcium Channel Calmodulin
Psoralenoside is a benzofuran glycoside from Psoralea corylifolia . Psoralenoside exhibits high binding affinities against histaminergic H₁, *calmodulin, and voltage-gated L-type calcium channels* (E-value≥-6.5 Kcal/mol) . Psoralenoside shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity .

HY-N12405

Encecalinol	Ageratina grandifolia (Regel) R.M.King & H.Rob. Coumarins Phenylpropanoids Plants Compositae Source Classification	Calmodulin
Encecalinol, extracted from aerial parts of Ageratina grandifolia, is a potent inhibitor of *calmodulin* inhibitor .

HY-N10198

Acremonidin A	Cardiovascular Disease Microorganisms Classification of Application Fields Phenols Polyphenols Disease Research Fields Source Classification	Endogenous Metabolite Calmodulin
Acremonidin A is a potent calmodulin (CaM) inhibitor found in Purpureocillium lilacinum. Acremonidin A binds to the human calmodulin (hCaM) biosensor hCaM M124C-mBBr, with K_d of 19.40 nM .

HY-N12411

(S)-O-Methylencecalinol	Natural Products Ageratina grandifolia (Regel) R.M.King & H.Rob. Plants Compositae Source Classification	Calmodulin
(S)-O-Methylencecalinol (compound 10) is a calmodulin-targeting molecule isolated from the aerial parts of Ageratina grandifolia .

HY-N12410

3,5-Diprenyl-4-hydroxyacetophenone	Ageratina grandifolia (Regel) R.M.King & H.Rob. Monophenols Phenols Plants Compositae Source Classification	Others
3,5-Diprenyl-4-hydroxyacetophenone (compound 8) is a calmodulin-targeting molecule compound isolated from the aerial parts of Ageratina grandifolia .

HY-N7503R

Psoralenoside (Standard)	Structural Classification Simple Phenylpropanols Leguminosae Phenylpropanoids Psoralea corylifolia L. Plants Source Classification	Reference Standards Histamine Receptor Calcium Channel Calmodulin
Psoralenoside is a benzofuran glycoside from Psoralea corylifolia . Psoralenoside exhibits high binding affinities against histaminergic H1, calmodulin, and voltage-gated L-type calcium channels (E-value≥-6.5 Kcal/mol) . Psoralenoside shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity .

HY-N7733

Fasciculic acid A	Microorganisms Antibiotics Other Antibiotics Source Classification	Calmodulin
Fasciculic acid A is a steroid that can be isolated from Hypholoma lateritium. Fasciculic acid B has antiinflammatory and *calmodulin* antagonistic activity .

HY-125412

Fasciculic acid B	Triterpenes Microorganisms Terpenoids Source Classification	Calmodulin
Fasciculic acid B is a steroid that can be isolated from Hypholoma lateritium. Fasciculic acid B has antiinflammatory and *calmodulin* antagonistic activity .

HY-142087

Beauverolide Ja	Natural Products Microorganisms Source Classification	Calmodulin Endogenous Metabolite
Beauverolide Ja, a cyclotetradepsipeptide, is a potent calmodulin (CaM) inhibitor with a K_d of 0.078 μM and a K_i of 0.39 μM for Ca ²⁺-CaM. Beauverolide Ja is a secondary metabolite of Isaria fumosorosea .

HY-N18431

Stellettamide A TFA ST-A TFA	Structural Classification Polysaccharides Iridoids Terpenoids Marine algae Marine natural products Sponge Saccharides Source Classification	Fungal
Stellettamide A TFA is a marine toxin found in a marine sponge. Stellettamide A TFA is a calmodulin inhibitor. Stellettamide A TFA can inhibit Ca ²⁺/Mg ²⁺ ATPase, phosphodiesterase, myosin light chain , and Mg ²⁺-ATPase. Stellettamide A TFA inhibits high K ⁺- and Ca ²⁺-induced contraction in permeabilized smooth muscle. Stellettamide A TFA exhibits antifungal activity against Mortierella remannianus. Stellettamide A TFA can be used for the research of fungal infection .

HY-114554

KS 619-1	Structural Classification Microorganisms Xanthones Phenols Source Classification	Phosphodiesterase (PDE) PKC Bacterial
KS 619-1 is a Ca ²⁺/calmodulin-dependent cyclic nucleotide phosphodiesterase inhibitor. KS 619-1 exhibits strong inhibitory activity against this enzyme derived from bovine brain and heart, but shows weak inhibitory effects on calmodulin-independent phosphodiesterase and protein kinase C. KS 619-1 displays weak antibacterial activity against Staphylococcus aureus .

HY-P2209

Nummularine B Daechuine S27; N-Demethylamphibine H	Structural Classification Alkaloids Other Alkaloids Plants Actaea simplex (DC.) Wormsk. ex Fisch. & C. A. Mey. Rhamnaceae Source Classification	Parasite Phosphodiesterase (PDE)
Nummularine B (Daechuine S27; N-Demethylamphibine H) is an anti-parasite agent. Nummularine B inhibits calmodulin-dependent phosphodiesterase activity with an IC₅₀ of 16.8 μM. Nummularine B inhibits the growth of Plasmodium and Leishmania donovani in vitro. Nummularine B inhibits the calmodulin-dependent activity of actomyosin Ca ²⁺-ATPase. Nummularine B is applicable to research related to malaria and visceral leishmaniasis .

HY-N18114

rel-(E)-6,7-Transdihydroxyligustilide	Structural Classification Polygonaceae Other Phenylpropanoids Phenylpropanoids Fallopia multiflora (Thunb.) Harald. Plants Source Classification	Calcium Channel
rel-(E)-6,7-Transdihydroxyligustilide is a compound found in the dried tuberous roots of Polygonum multiflorum. rel-(E)-6,7-Transdihydroxyligustilide inhibits Ca ²⁺‑ATPase in calmodulin-deficient human erythrocyte membranes. rel-(E)-6,7-Transdihydroxyligustilide is used for the research of hyperlipidemia .

HY-W720917

Junicedric acid	Structural Classification Pinaceae Terpenoids Diterpenoids Plants Pinus merkusii Jungh. & de Vriese Source Classification	CaMK PKC Amyloid-β Apoptosis
Junicedric acid is a diterpenoid compound that can be isolated from the resin of the Araucaria araucana tree. Junicedric acid exerts neuroprotective activity by increasing intracellular calcium levels in hippocampal neurons, activating PKC and *calcium/calmodulin-dependent protein kinase* (CaMKII), and preventing Amyloid-β oligomer-induced synaptic protein loss, apoptosis, and long-term potentiation (LTP) inhibition. Junicedric acid can be used in the study of the pathological mechanisms of neurodegenerative diseases such as Alzheimer's disease .

Species:	Human (19) Rat (1) Mouse (1)
Tag:	His (9) Tag Free (5) GST (14)
Source:	HEK293 (1) Sf9 insect cells (13) E. coli (8)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P703476

	CALM3 Protein, Tetronarce californica Calmodulin; Tetronarce californica; Pacific electric ray; CaM	Others	E. coli
	CALM3 Protein, Tetronarce californica is the recombinant CALM3, expressed by E. coli , with tag Free labeled tag.

HY-P7710

	Calmodulin Protein, Human 1 Publications Verification rHuCalmodulin; Calmodulin; CaM; CALM1	Human	E. coli
	Calmodulin Protein, Human is a recombinant human Calmodulin expressed in E. coli. Calmodulin is a low molecular weight, acidic, calcium binding protein which mediates the Ca²⁺ regulation of a wide range of physiological processes throughout eukaryotic organisms.

HY-P76760

	CALML5 Protein, Human (His) Calmodulin-like protein 5; Calmodulin-like skin protein; CLSP	Human	E. coli
	The CALML5 protein is known for its calcium-binding ability and may be involved in terminal differentiation of keratinocytes, suggesting a role in skin cell maturation. Its association with transglutaminase 3 suggests cooperation in skin development function. CALML5 Protein, Human (His-GST) is the recombinant human-derived CALML5 protein, expressed by E. coli , with N-His, N-GST labeled tag.

HY-P72110

	CALML3 Protein, Human (GST) CALL3_HUMAN; CALML3; Calmodulin like 3; Calmodulin related protein NB 1; Calmodulin-like protein 3; Calmodulin-related protein NB-1; CaM like protein; CaM-like protein; CLP; OTTHUMP00000019004	Human	E. coli
	The CALML3 protein has a dual role, acting as a specific light chain of unconventional myosin 10 (MYO10) and enhancing MYO10 translation. CALML3 has a potential molecular chaperone role and contributes to the synthesis of the emerging MYO10 heavy chain protein. CALML3 Protein, Human (GST) is the recombinant human-derived CALML3 protein, expressed by E. coli , with N-GST labeled tag.

HY-P702652

	CAMKIV/CAMK4 Protein, Human (Active, sf9, GST) CAMK4; calcium/Calmodulin-dependent protein kinase IV; calcium/Calmodulin-dependent protein kinase type IV	Human	Sf9 insect cells
	CAMKIV/CAMK4 Protein, Human (sf9, GST) is the recombinant human-derived CAMKIV/CAMK4, expressed by Sf9 insect cells , with GST labeled tag.

HY-P75461

	CALM2 Protein, Human (His) Calmodulin-2; CAM2; CAMB	Human	E. coli
	The CALM2 protein is an important component of calcium signaling, controlling enzymes, ion channels, and aquaporins through calcium binding. CALM2 Protein, Human (His) is the recombinant human-derived CALM2 protein, expressed by E. coli , with N-His labeled tag.

HY-P702654

	CAMK1 alpha/CAMK1 Protein, Human (Active, sf9, His, GST) CAMK1; calcium/Calmodulin-dependent protein kinase I; calcium/Calmodulin-dependent protein kinase type 1; CaMKI; caM-KI; caMKI-alpha; caM kinase I alpha; CAMKI; MGC120317; MGC120318;	Human	Sf9 insect cells
	CAMK1 alpha/CAMK1 Protein, Human (sf9, His, GST) is the recombinant human-derived CAMK1 alpha, expressed by Sf9 insect cells , with His, GST labeled tag.

HY-P75457

	CAMKIV/CAMK4 Protein, Mouse (sf9) Calcium/Calmodulin-dependent protein kinase type IV; CaMK IV; CAMK4; CAMK; CAMK-GR	Mouse	Sf9 insect cells
	CAMKIV/CAMK4 protein, a calcium/calmodulin-dependent kinase, regulates transcription activators (CREB1, MEF2D, JUN, and RORA) in immune response, inflammation, and memory consolidation. It controls thymocyte selection, TCR signaling, osteoclast and dendritic cell survival, and memory consolidation in hippocampal neurons. It activates MAP kinases, ELK1, ATF2, and potentially participates in spermatogenesis. CAMKIV/CAMK4 Protein, Mouse (sf9) is the recombinant mouse-derived CAMKIV/CAMK4 protein, expressed by Sf9 insect cells, with tag free.

HY-P76761

	CaMKII alpha/CAMK2A Protein, Human (Active, sf9, GST) Calcium/Calmodulin-dependent protein kinase type II subunit alpha; CAMKA	Human	Sf9 insect cells
	CaMKII α/CAMK2A protein functions autonomously upon Ca(2+)/calmodulin binding and autophosphorylation. CaMKII alpha/CAMK2A Protein, Human (sf9, GST) is the recombinant human-derived CaMKII alpha/CAMK2A protein, expressed by Sf9 insect cells , with N-GST labeled tag.

HY-P701722

	CAMKK1 Protein, Human (sf9) CAMKK1; Calcium/Calmodulin-dependent protein kinase kinase 1; CaM-KK 1; CaM-kinase kinase 1; CaMKK 1; CaM-kinase IV kinase; Calcium/Calmodulin-dependent protein kinase kinase alpha; CaM-KK alpha; CaM-kinase kinase alpha; CaMKK alpha	Human	Sf9 insect cells
	The CAMKK1 protein is a calcium/calmodulin-dependent kinase and a key player in calcium-triggered signaling cascades involved in various cellular processes. It phosphorylates multiple members of the CAMK1 family, including CAMK1, CAMK1D, CAMK1G, and CAMK4. CAMKK1 Protein, Human (sf9) is the recombinant human-derived CAMKK1 protein, expressed by sf9 insect cells , with tag free.

HY-P701723

	CAMKK1 Protein, Human (Inactive, sf9, His) CAMKK1; Calcium/Calmodulin-dependent protein kinase kinase 1; CaM-KK 1; CaM-kinase kinase 1; CaMKK 1; CaM-kinase IV kinase; Calcium/Calmodulin-dependent protein kinase kinase alpha; CaM-KK alpha; CaM-kinase kinase alpha; CaMKK alpha	Human	Sf9 insect cells
	The CAMKK1 protein is a calcium/calmodulin-dependent kinase and a key player in calcium-triggered signaling cascades involved in various cellular processes. It phosphorylates multiple members of the CAMK1 family, including CAMK1, CAMK1D, CAMK1G, and CAMK4. CAMKK1 Protein, Human (sf9, His) is the recombinant human-derived CAMKK1 protein, expressed by sf9 insect cells , with N-6*His labeled tag.

HY-P703030

	CAMKK1 Protein, Rat (F230G, sf9, GST) Calcium/Calmodulin-dependent protein kinase kinase 1; CaM-KK 1; CaM-kinase kinase 1; CaMKK 1; CaM-kinase IV kinase; Calcium/Calmodulin-dependent protein kinase kinase alpha (CaM-KK alpha; CaM-kinase kinase alpha; CaMKK alpha)	Rat	Sf9 insect cells
	CAMKK1 Protein, Rat (F230G, sf9, GST) is the recombinant rat-derived CAMKK1, expressed by Sf9 insect cells , with GST labeled tag.

HY-P76762

	CaMKII beta/CAMK2B Protein, Human (Active, sf9, His-GST) Calcium/Calmodulin-dependent protein kinase type II subunit beta; CAM2; CAMK2; CAMKB	Human	Sf9 insect cells
	CaMKII beta/CAMK2B is a calcium/calmodulin-dependent protein kinase that functions autonomously upon Ca(2+)/calmodulin binding and autophosphorylation. It plays an important role in dendritic spine and synapse formation, neuronal plasticity, and the regulation of skeletal muscle sarcoplasmic reticulum Ca(2+) transport. CaMKII beta/CAMK2B Protein, Human (sf9, His-GST) is the recombinant human-derived CaMKII beta/CAMK2B protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag.

HY-P705662

	CAMKI alpha/CAMK1 Protein, Human (Active) rHuCAMK1, His; Calcium/Calmodulin-Dependent Protein Kinase Type 1; CaM Kinase I; CaMKI-Alpha; CAMK1	Human	E. coli
	CAMKI alpha/CAMK1 Protein, Human, a recombinant human CAMK1 produced in HEK293 cells. CAMK1 is involved in multiple cell functions, including calmodulin binding, ATP binding, signal transduction, development and cell differentiation.

HY-P7715

	CAMKI delta/CAMK1D Protein, Human (GST) rHuCAMK1D, N-GST; Calcium/Calmodulin-dependent protein kinase type 1D; CaMKI-like protein kinase; CAMK1D;	Human	E. coli
	CAMKI delta/CAMK1D Protein, Human (GST), a recombinant human CAMK1D expressed in E. coli, has a GST tag at the N-terminus. CAMK1D acts as a key modulator of tumor-intrinsic immune resistance.

HY-P76191

	CAMKI gamma/CAMK1G Protein, Human (Active, sf9, His, GST) Calcium/Calmodulin-dependent protein kinase type 1G; CaMKI gamma; CLICK III; CLICK3; VWS1	Human	Sf9 insect cells
	The CAMK1G protein is a calcium/calmodulin-dependent protein kinase and a key component of the proposed calcium-triggered signaling cascade. This kinase exhibits the ability to phosphorylate the transcription factor CREB1 in vitro, suggesting its involvement in regulating cellular processes related to gene expression and transcriptional control. CAMKI gamma/CAMK1G Protein, Human (sf9, His, GST) is the recombinant human-derived CAMKI gamma/CAMK1G protein, expressed by Sf9 insect cells , with His, GST labeled tag.

HY-P7714

	CAMKI alpha/CAMK1 Protein, Human (Active, HEK293, His) rHuCAMK1, His; Calcium/Calmodulin-Dependent Protein Kinase Type 1; CaM Kinase I; CaMKI-Alpha; CAMK1	Human	HEK293
	CAMKI alpha/CAMK1 Protein, Human (HEK293, His), a recombinant human CAMK1 produced in HEK293 cells, has a His tag at the N-terminus. CAMK1 is involved in multiple cell functions, including calmodulin binding, ATP binding, signal transduction, development and cell differentiation.

HY-P75960

	PDE1B Protein, Human (sf9, His-GST) Calcium/Calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B; Cam-PDE 1B; PDE1B1; PDES1B	Human	Sf9 insect cells
	PDE1B protein, a cyclic nucleotide phosphodiesterase, displays dual specificity for cAMP and cGMP, essential second messengers in physiological processes. Preferring cGMP as a substrate, PDE1B fine-tunes cellular responses to cyclic nucleotide signaling. Its dual specificity underscores its regulatory role in diverse physiological pathways. PDE1B Protein, Human (sf9, His-GST) is the recombinant human-derived PDE1B protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag.

HY-P702653

	CAMK1 delta Protein, Human (Active, sf9, GST) Calcium/Calmodulin-dependent protein kinase type 1D; CaM kinase I delta; CaM kinase ID; CaM-KI delta; CaMKI delta; CaMKID	Human	Sf9 insect cells
	CAMK1 delta Protein, Human (sf9, GST) is the recombinant human-derived CAMK1 delta, expressed by Sf9 insect cells , with GST labeled tag.

HY-P701676

	EEF2K Protein, Human (Active, GST) 1 Publications Verification EEF2K; Eukaryotic elongation factor 2 kinase; eEF-2 kinase; eEF-2K; Calcium/Calmodulin-dependent eukaryotic elongation factor 2 kinase	Human	E. coli
	EEF2K, a threonine kinase, critically regulates protein synthesis by modulating peptide chain elongation. Activation by upstream kinases like AMPK or TRPM7 leads to phosphorylation of EEF2, inhibiting its binding to ribosomes and decelerating protein synthesis. EEF2K's intricate control underscores its pivotal role in modulating cellular processes related to protein translation. EEF2K Protein, Human (GST) is the recombinant human-derived EEF2K protein, expressed by E. coli , with N-GST labeled tag.

HY-P701720

	CaMKII delta/CAMK2D Protein, Human (Active, sf9, GST) CAMK2D; Calcium/Calmodulin-dependent protein kinase type II subunit delta; CaM kinase II subunit delta; CaMK-II subunit delta	Human	Sf9 insect cells
	CAMK2D protein regulates calcium levels and excitation-contraction coupling in the heart. CaMKII delta/CAMK2D Protein, Human (sf9, GST) is the recombinant human-derived CAMK2D protein, expressed by sf9 insect cells , with N-GST labeled tag.

HY-P701757

	PNCK Protein, Human (Active, sf9, His, GST) PNCK; Calcium/Calmodulin-dependent protein kinase type 1B; CaM kinase I beta; CaM kinase IB; CaM-KI beta; CaMKI-beta; Pregnancy up-regulated non-ubiquitously-expressed CaM kinase	Human	Sf9 insect cells
	The PNCK protein is a calcium/calmodulin-dependent protein kinase and a key component of the calcium-triggered signaling cascade. In vitro, PNCK exhibits the ability to phosphorylate CREB1 and SYN1/synapsin I, emphasizing its involvement in regulating cellular processes associated with these substrates. PNCK Protein, Human (sf9, His, GST) is the recombinant human-derived PNCK protein, expressed by sf9 insect cells , with N-8*His, N-GST labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-B0532AS

Trifluoperazine-d3 dihydrochloride

Trifluoperazine-d₃ (dihydrochloride) is deuterium labeled Trifluoperazine (dihydrochloride). Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis .

Host:	Mouse (8) Rabbit (12)
Reactivity:	Human (17) Rat (13) Mouse (15) Monkey (1) Sheep (1) Chicken (1) Species independent (1) Dog (1) Pig (2)
Application:	IHC-P (9) ICC/IF (8) IF-Tissue (2) IP (4) IHC-F (2) WB (19) FC (8)
Isotype:	IgG (12) IgG1 (3) IgG2a (1)
Conjugation:	Non-conjugated (20)
Clonality:	Polyclonal (1) Monoclonal (16) Recombinant (10)
Modification:	Phosphorylated (1) Unmodified (16)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P810536

	Phospho-CaMKII (Thr286) Antibody (YA9806) Alpha CaMKII; Calcium Calmodulin dependent protein kinase II; Calcium/Calmodulin dependent protein kinase II alpha B subunit; Calcium/Calmodulin dependent protein kinase type II alpha chain; Calcium/Calmodulin-dependent protein kinase (CaM kinase) II alpha; Calcium/Calmodulin-dependent protein kinase II alpha; Calcium/Calmodulin-dependent protein kinase II-alpha; Calcium/Calmodulin-dependent protein kinase type II subunit alpha; Calcium/Calmodulin-dependent protein kinase type IIA; CaM kinase II alpha chain	WB, IHC-P, IP, ICC/IF, IF-Tissue	Human, Mouse, Rat
	Phospho-CaMKII (Thr286) Antibody (YA9806) is a Mouse-derived and non-conjugated IgG1 Monoclonal antibody, targeting to Phospho-CaMKII (Thr286).

HY-P85537

	CaMKIV Antibody (YA5229) Brain Ca; 2; Calmodulin dependent protein kinase type 4; Brain Ca; 2; Calmodulin dependent protein kinase type IV; Brain Ca -Calmodulin dependent protein kinase type IV; Calcium / Calmodulin dependent protein kinase type 4 catalytic chain; Calcium / Calmodulin dependent protein kinase type IV catalytic chain; Calcium/Calmodulin dependent protein kinase IV; Calcium/Calmodulin dependent protein kinase type IV; Calcium/Calmodulin-dependent protein kinase type IV; CAM kinase 4; CAM kinase GR; CAM kinase IV; CAM kinase-GR; CaMK 4; CAMK GR; CaMK IV; CaMK4; CaMKGR; IV; KCC4_HUMAN; MGC36771.	WB	Human
	CaMKIV Antibody (YA5229) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CaMKIV.

HY-P81569

	CBP Tag Antibody (YA1314) Calmodulin binding peptide,KRRWKKNFIAVSAANRFKKISSSGAL	WB	Species independent
	CBP Tag Antibody (YA1314) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CBP Tag.

HY-P81205

	CAMKK2 Antibody Calcium/Calmodulin dependent protein kinase beta; Calcium/Calmodulin dependent protein kinase kinase 2; Calcium/Calmodulin dependent protein kinase kinase beta; CaM kinase kinase beta; CaM KK beta; CAMKK 2; CAMKK; CaMKK beta; CAMKK beta protein; CAMKKB.	WB, IHC-P, IHC-F, FC	Human, Mouse, Rat, Sheep
	CAMKK2 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to CAMKK2.

HY-P80445

	CaMKII alpha Antibody (YA569) 2 Publications Verification Alpha CaMKII; Calcium Calmodulin dependent protein kinase II; Calcium/Calmodulin dependent protein kinase II alpha B subunit; Calcium/Calmodulin dependent protein kinase type II alpha chain; Calcium/Calmodulin-dependent protein kinase (CaM kinase) II alpha; Calcium/Calmodulin-dependent protein kinase II alpha; Calcium/Calmodulin-dependent protein kinase II-alpha; Calcium/Calmodulin-dependent protein kinase type II subunit alpha; Calcium/Calmodulin-dependent protein kinase type IIA; CaM kinase II alpha chain; CaM kinase II alpha subunit; CaM kinase II subunit alpha; CaMK II alpha subunit; CaMK-II subunit alpha; Camk2a; CAMKA; CaMKII; CaMKIINalpha; EC2.7.11.17; KCC2A_HUMAN; KIAA0968; MGC123320; MGC139375; MGC155201; mKIAA0968; PK2CDD; PKCCD; R74975; zgc:112538; zgc:123320;	WB, IP, FC, IHC-P	Human, Mouse, Rat
	CaMKII alpha Antibody (YA569) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CaMKII alpha.

HY-P86799

	CASK Antibody (YA6492) CAGH39 antibody; Caki antibody; Calcium/Calmodulin dependent serine protein kinase antibody; Calcium/Calmodulin dependent serine protein kinase (MAGUK family) antibody; Calcium/Calmodulin dependent serine protein kinase membrane associated guanylate kinase antibody; Calcium/Calmodulin-dependent serine protein kinase antibody; CAMGUK antibody; CAMGUK protein antibody; CAMGUK, drosophila, homolog of antibody; casK antibody; CAGH39 antibody; Caki antibody; Calcium/Calmodulin dependent serine protein kinase antibody; Calcium/Calmodulin dependent serine protein kinase (MAGUK family) antibody; Calcium/Calmodulin dependent serine protein kinase membrane associated guanylate kinase antibody; Calcium/Calmodulin-dependent serine protein kinase antibody; CAMGUK antibody; CAMGUK protein antibody; CAMGUK, drosophila, homolog of antibody; casK antibody; CMG antibody; CSKP_HUMAN antibody; DXPri1 antibody; DXRib1 antibody; FGS4 antibody; FLJ22219 antibody; FLJ31914 antibody; hCASK antibody; LIN 2 antibody; Lin 2 homolog antibody; LIN2 antibody; Lin2 homolog antibody; MICPCH antibody; MRXSNA antibody; Pals3 antibody; Peripheral plasma membrane protein CASK antibody; Protein lin-2 homolog antibody; TNRC8 antibody; Trinucleotide repeat containing 8 antibody; Vertebtate LIN2 homolog antibody;	WB, IHC-P	Human, Mouse, Rat
	CASK Antibody (YA6492) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CASK.

HY-P84930

	CaMKII Antibody (YA4627) 1 Publications Verification Calcium/Calmodulin dependent protein kinase II alpha antibody; Calcium/Calmodulin dependent protein kinase II beta antibody; Calcium/Calmodulin dependent protein kinase II delta antibody; Calcium/Calmodulin dependent protein kinase II gamma antibody; Calcium/Calmodulin-dependent protein kinase type II subunit alpha antibody; CaM kinase II alpha antibody; CaM kinase II antibody; CaM kinase II beta antibody; CaM kinase II delta antibody; CaM kinase II gamma antibody; CaM kinase II subunit alpha antibody; CaMK-II subunit alpha antibody; CAMK2 antibody; Camk2a antibody; CAMK2B antibody; CAMK2D antibody; CAMK2G antibody; CAMKA antibody; KCC2A_HUMAN antibody; CaMKⅡ	WB, IHC-P, IHC-F, ICC/IF, FC, IF-Tissue	Human, Mouse, Rat, Monkey, Pig
	CaMKII Antibody (YA4627) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CaMKII.

HY-P86858

	EEF2K Antibody (YA6551) C86191 antibody; Calcium/Calmodulin dependent eukaryotic elongation factor 2 antibody; Calcium/Calmodulin dependent eukaryotic elongation factor 2 kinase antibody; Calcium/Calmodulin-dependent eukaryotic elongation factor 2 kinase antibody; Calmodulin dependent protein kinase III antibody; cb365 antibody; EC 2.7.11.20 antibody; eEF 2 kinase antibody; eEF 2K antibody; eEF-2 kinase antibody; C86191 antibody; Calcium/Calmodulin dependent eukaryotic elongation factor 2 antibody; Calcium/Calmodulin dependent eukaryotic elongation factor 2 kinase antibody; Calcium/Calmodulin-dependent eukaryotic elongation factor 2 kinase antibody; Calmodulin dependent protein kinase III antibody; cb365 antibody; EC 2.7.11.20 antibody; eEF 2 kinase antibody; eEF 2K antibody; eEF-2 kinase antibody; eEF-2K antibody; Eef2k antibody; EEF2K protein antibody; EF2K_HUMAN antibody; Elongation factor 2 kinase antibody; Eukaryotic elongation factor 2 kinase antibody; fa04b08 antibody; HSU93850 antibody; kinase eEF2K antibody; MGC45041 antibody; SMEF2K antibody; wu:fa04b08 antibody; zgc:100973 antibody;	WB, ICC/IF, FC	Human, Mouse, Rat
	EEF2K Antibody (YA6551) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to EEF2K.

HY-P82082

	Calmodulin Antibody (YA1827) CALM; CALM1; CALM2; CALM3; CAM; CAM1; CAM2; CAM3; CAMB; CAMC	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	Calmodulin Antibody (YA1827) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Calmodulin.

HY-P82599

	CaMKII beta Antibody (YA2344) CAMK2B; CAM2; CAMK2; CAMKB; Calcium/Calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; CAMK2G; CAMK; CAMK-II; CAMKG; Calcium/Calmodulin-dependent protein kinase type II subunit gamma	WB	Mouse
	CaMKII beta Antibody (YA2344) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CaMKII beta.

HY-P86066

	Phospho-CaMKIIβ/γ/δ Antibody (YA5758) CAMK2B; CAM2; CAMK2; CAMKB; Calcium/Calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; CAMK2G; CAMK; CAMK-II; CAMKG; Calcium/Calmodulin-dependent protein kinase type II subunit gamma;	IHC-P, ICC/IF	Human, Rat, Mouse
	Phospho-CaMKIIβ/γ/δ Antibody (YA5758) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Phospho-CaMKIIβ/γ/δ.

HY-P82599A

	CaMKII beta Antibody (YA2344)(PBS only) CAMK2B; CAM2; CAMK2; CAMKB; Calcium/Calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; CAMK2G; CAMK; CAMK-II; CAMKG; Calcium/Calmodulin-dependent protein kinase type II subunit gamma	WB	Mouse
	CaMKII beta Antibody (YA2344) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CaMKII beta.

HY-P810546

	Phospho-CaMKII (Thr286) Antibody (YA9815) CAMK2B; CAM2; CAMK2; CAMKB; Calcium/Calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; CAMK2G; CAMK; CAMK-II; CAMKG; Calcium/Calmodulin-dependent protein kinase type II subunit gamma	WB	Human, Mouse, Rat
	Phospho-CaMKII (Thr286) Antibody (YA9815) is a Rabbit-derived and non-conjugated IgG Recombinant, Monoclonal antibody, targeting to Phospho-CaMKII (Thr286).

HY-P81263A

	CaMKIV Antibody (YA943) CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/Calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR	WB, IHC-P, ICC/IF, IP, FC	Human
	CaMKIV Antibody (YA943) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CaMKIV.

HY-P81263

	CaMKIV Antibody (YA942) CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/Calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR	WB	Human
	CaMKIV Antibody (YA942) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to CaMKIV.

HY-P85421

	CaMKIV Antibody (YA5113) CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/Calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR	WB	Human, Mouse, Rat, Chicken, Dog, Pig
	CaMKIV Antibody (YA5113) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CaMKIV.

HY-P87013

	PPM1E Antibody (YA6706) Ca(2+)/Calmodulin-dependent protein kinase phosphatase N antibody; CaMKN antibody; CaMKP-N antibody; CaMKP-nucleus antibody; KIAA1072 antibody; Nuclear Calmodulin dependent protein kinase phosphatase antibody; Partner of PIX 1 antibody; Partner of PIX-alpha antibody; Partner of PIXA antibody; POPX1 antibody; Ca(2+)/Calmodulin-dependent protein kinase phosphatase N antibody; CaMKN antibody; CaMKP-N antibody; CaMKP-nucleus antibody; KIAA1072 antibody; Nuclear Calmodulin dependent protein kinase phosphatase antibody; Partner of PIX 1 antibody; Partner of PIX-alpha antibody; Partner of PIXA antibody; POPX1 antibody; PP2CH antibody; Ppm1e antibody; PPM1E_HUMAN antibody; Protein phosphatase 1E antibody; Protein phosphatase Mg2+/Mn2+ dependent 1E antibody;	WB	Human
	PPM1E Antibody (YA6706) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PPM1E.

HY-P82763

	Calcineurin A Antibody (YA2508) PPP3CA; CALNA; CNA; Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform; CAM-PRP catalytic subunit; Calmodulin-dependent calcineurin A subunit alpha isoform	WB, ICC/IF, FC	Human, Mouse, Rat
	Calcineurin A Antibody (YA2508) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Calcineurin A.

HY-P85455

	Calcineurin A Antibody (YA5147) PPP3CA; CALNA; CNA; Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform; CAM-PRP catalytic subunit; Calmodulin-dependent calcineurin A subunit alpha isoform	WB	Human, Mouse, Rat
	Calcineurin A Antibody (YA5147) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Calcineurin A.

HY-P87014

	PPP3CB Antibody (YA6707) Calcineurin A beta antibody; Calcineurin A2 antibody; Calcineurin B, formerly antibody; Calmodulin dependent calcineurin A subunit beta isoform antibody; Calmodulin-dependent calcineurin A subunit beta isoform antibody; CALNA 2 antibody; CALNA2 antibody; CALNB antibody; CAM PRP catalytic subunit antibody; CAM-PRP catalytic subunit antibody; Calcineurin A beta antibody; Calcineurin A2 antibody; Calcineurin B, formerly antibody; Calmodulin dependent calcineurin A subunit beta isoform antibody; Calmodulin-dependent calcineurin A subunit beta isoform antibody; CALNA 2 antibody; CALNA2 antibody; CALNB antibody; CAM PRP catalytic subunit antibody; CAM-PRP catalytic subunit antibody; CNA2 antibody; CnAbeta antibody; PP2BB_HUMAN antibody; PP2Bbeta antibody; PPP3CB antibody; Protein phosphatase 2B, catalytic subunit, beta isoform, formerly antibody; Protein phosphatase 3 (formerly 2B) catalytic subunit beta isoform antibody; Protein phosphatase 3 catalytic subunit beta isoform antibody; Protein phosphatase 3 catalytic subunit beta isozyme antibody; Serine/threonine protein phosphatase 2B catalytic subunit beta isoform antibody; Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform antibody;	WB, IHC-P, ICC/IF, FC	Human, Mouse, Rat
	PPP3CB Antibody (YA6707) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PPP3CB.